Distinct Characteristics of Pleuroparenchymal Fibroelastosis With Usual Interstitial Pneumonia Compared With Idiopathic Pulmonary Fibrosis

Size: px
Start display at page:

Download "Distinct Characteristics of Pleuroparenchymal Fibroelastosis With Usual Interstitial Pneumonia Compared With Idiopathic Pulmonary Fibrosis"

Transcription

1 [ Original Research Diffuse Lung Disease ] Distinct Characteristics of Pleuroparenchymal Fibroelastosis With Usual Interstitial Pneumonia Compared With Idiopathic Pulmonary Fibrosis Tsuneyuki Oda, MD ; Takashi Ogura, MD ; Hideya Kitamura, MD, PhD ; Eri Hagiwara, MD, PhD ; Tomohisa Baba, MD ; Yasunori Enomoto, MD ; Tae Iwasawa, MD, PhD ; Koji Okudela, MD, PhD ; Tamiko Takemura, MD, PhD ; Fumikazu Sakai, MD, PhD ; and Yoshinori Hasegawa, MD, PhD, FCCP BACKGROUND: Pleuroparenchymal fibroelastosis (PPFE) is a rare form of interstitial pneumonia and sometimes coexists with a histologic usual interstitial pneumonia (UIP) pattern. This study aimed to describe the distinct clinical features of PPFE with UIP pattern compared with idiopathic pulmonary fibrosis (IPF). METHODS: We conducted a retrospective review of the medical records of 110 consecutive patients with IPF with a histologic UIP pattern on surgical lung biopsy specimen. Patients meeting radiologic criteria for the diagnosis of PPFE based on high-resolution CT scan and with a histologic UIP pattern were included. RESULTS: Nine of eleven patients meeting radiologic criteria for the diagnosis of PPFE were histologically confirmed as having PPFE with UIP pattern. The PPFE with UIP pattern group showed a significantly higher residual volume (1.8 L vs 1.3 L, P,.01), higher Paco 2 (44.6 mm Hg vs 41.7 mm Hg, P 5.04), and higher complication rate of pneumothorax and pneumomediastinum than the 99 patients with IPF/UIP. The ratio of anteroposterior to transthoracic diameter in patients with PPFE with UIP pattern was significantly lower than that in patients with IPF/UIP ( P 5.04). Survival time tended to be shorter in patients with PPFE with UIP pattern. CONCLUSIONS: The results support the view that PPFE with UIP pattern is a disease entity distinct from IPF/UIP and may well be classified as PPFE. CHEST 2014; 146( 5 ): Manuscript received December 4, 2013; revision accepted May 26, 2014; originally published Online First June 19, ABBREVIATIONS: APDT 5 anteroposterior diameter of the thorax; ATS 5 American Thoracic Society; ERS 5 European Respiratory Society; HRCT 5 high-resolution CT; IPF 5 idiopathic pulmonary fibrosis; PPFE 5 pleuroparenchymal fibroelastosis; RV 5 residual volume; TDT 5 transthoracic diameter of the thorax; TLC 5 total lung capacity; UIP 5 usual interstitial pneumonia AFFILIATIONS: From the Department of Respiratory Medicine (Drs Oda, Ogura, Kitamura, Hagiwara, Baba, and Enomoto) and Department of Radiology (Dr Iwasawa), Kanagawa Cardiovascular and Respiratory Center, Yokohama; Department of Pathobiology (Dr Okudela), Yokohama City University Graduate School of Medicine, Yokohama; Department of Pathology (Dr Takemura), Japan Red Cross Medical Center, Tokyo; Department of Diagnostic Radiology (Dr Sakai), International Medical Center of Saitama Medical University, Saitama; and Department of Respiratory Medicine (Drs Oda and Hasegawa), Nagoya University Graduate School of Medicine, Nagoya, Japan. FUNDING/SUPPORT: This study was supported in part by a grant-in-aid for interstitial lung diseases from the Japanese Ministry of Health, Labor and Welfare [Grant H23-Nanchi-Ippan-023]. CORRESPONDENCE TO: Takashi Ogura, MD, Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Tomioka-higashi, Kanazawa-ku, Yokohama , Japan; ogura@kanagawa-junko.jp 2014 AMERICAN COLLEGE OF CHEST PHYSICIANS. Reproduction of this article is prohibited without written permission from the American College of Chest Physicians. See online for more details. DOI: /chest Original Research [ 146 # 5 CHEST NOVEMBER 2014 ]

2 Idiopathic pleuroparenchymal fibroelastosis (PPFE) is a rare form of interstitial pneumonia. In 2004, five cases were reported of a unique idiopathic pleuroparenchymal lung disease characterized by a chronic idiopathic interstitial pneumonia with upper lobe-predominant marked pleural and parenchymal involvement. 1 The disease shares common features with idiopathic pulmonary upper lobe fibrosis proposed by Amitani et al. 2 Since, several case reports of PPFE have been published, 3-13 but no consensus has been reached regarding disease entity, characteristics, and diagnostic criteria. Lobar histologic variability is frequent in patients with idiopathic interstitial pneumonia, and multiple histologic and high-resolution CT (HRCT) image patterns may coexist in the same patient. Cases with coexisting usual interstitial pneumonia (UIP) pattern and fibrotic nonspecific interstitial pneumonia pattern named as discordant UIP appear to behave similarly to those of concordant UIP. 14,15 One study on PPFE reported that HRCT imaging could show other interstitial lung disease patterns in other locations in some patients. 16 Indeed, specimens from patients with PPFE occasionally show a UIP pattern in the lower lobe (ie, PPFE with UIP pattern). Because PPFE with UIP pattern is regarded as inconsistent with UIP on HRCT scan and as UIP by histopathologic analysis, it is considered possible idiopathic pulmonary fibrosis (IPF) in accordance with the 2011 American Thoracic Society (ATS)/European Respiratory Society (ERS)/Japanese Respiratory Society/Latin American Thoracic Association official statement on IPF. 17 However, whether this diagnosis is appropriate when PPFE coexists with UIP pattern is not clear. This retrospective study has two objectives: to define the clinical and radiologic features of PPFE with UIP pattern compared with IPF/UIP by identifying PPFE with UIP pattern from surgically proven IPF/UIP and to determine whether PPFE with UIP pattern is a disease entity distinct from IPF/UIP. Materials and Methods Study Population We retrospectively reviewed medical records of 291 consecutive patients with idiopathic interstitial pneumonia who underwent surgical lung biopsy between January 2001 and December 2011 at Kanagawa Cardiovascular and Respiratory Center. Included were 110 consecutive patients with IPF diagnosed according to the 2002 ATS/ERS statement,18 with histologic UIP pattern shown in the biopsy specimen from the lower lobe. This study was approved by an institutional review board of Kanagawa Cardiovascular and Respiratory Center (approval number 24-14). Radiologic Criteria for PPFE Two expert pulmonary radiologists (T. I. and F. S.) identified patients according to the following radiologic criteria for the diagnosis of PPFE as previously reported in the literature 16 and without knowledge of their clinical background or histologic findings: Definite PPFE: demonstrating pleural thickening with associated subpleural fibrosis concentrated in the upper lobes, with involvement of lower lobes being less marked or absent. Consistent with PPFE: upper lobe pleural thickening with associated subpleural fibrosis present, but (1) distribution of these changes not concentrated in the upper lobes or (2) features of coexistent disease present elsewhere. Inconsistent with PPFE: lacking the requisite features just described. In this study, only patients with definite or consistent with PPFE by radiologic criteria were included. If the two radiologists disagreed, the final diagnosis was reached by consensus. HRCT scan had been performed within 2 months before surgical lung biopsy. Histologic Criteria for PPFE Surgical biopsies of multiple lobes were performed in all patients. All available slides were reviewed independently by two expert pulmonary pathologists (K. O. and T. T.) who were not aware of the clinical and radiologic findings for the patients. Patients with a possibility of chronic hypersensitivity pneumonitis, pneumoconiosis, fungal or mycobacterial infection, and connective tissue disease-related lung disease on biopsy specimens were excluded. Histologic UIP pattern was diagnosed according to the 2002 ATS/ERS consensus classification of idiopathic interstitial pneumonias. 18 Histologic criteria for the diagnosis of PPFE were previously described in the literature as follows 16 : Definite PPFE: upper zone pleural fibrosis with subjacent intraalveolar fibrosis accompanied by alveolar septal elastosis. Consistent with PPFE: intraalveolar fibrosis present but (1) not associated with pleural fibrosis, (2) not predominantly beneath the pleura, or (3) not observed in an upper lobe biopsy specimen. Inconsistent with PPFE: lacking the requisite features just described. If the two pathologists disagreed, the final diagnosis was reached by consensus. In this study, only patients with definite or consistent with PPFE by histologic criteria were included. Clinical and Radiologic Review The pulmonologists reviewed the medical records, pulmonary function data, and laboratory data, analyzing pulmonary function data obtained within 6 months before surgical lung biopsy. Radiologic features such as dense subpleural consolidation, honeycombing, and degree of flattened thoracic cage were also analyzed. The anteroposterior diameter of the thorax (APDT) was measured on HRCT scan as the longest distance of the anterior-posterior dimension of the thoracic cage at the level of the sixth thoracic vertebra. 19 The transthoracic diameter of the thorax (TDT) was measured as the longest transverse diameter of the thoracic cage at the level of the sixth thoracic vertebra. 19 The ratio of anteroposterior to transthoracic diameter was then derived. Survival analysis was performed from the time of initial consultation. Patients with clinical connective tissue disease, autoimmune disease, or hypersensitivity pneumonitis were excluded. Statistical Analysis Data are presented as mean SD unless otherwise stated. Fisher exact test or Mann-Whitney U test was used for between-group comparisons as appropriate. Survival time from initial consultation was analyzed by the Kaplan-Meier method and log-rank test, with the end points being death or last contact. P,.05 was considered significant. journal.publications.chestnet.org 1249

3 Results Patient Identification Eleven of the 110 consecutive patients with IPF met radiologic criteria for PPFE. Of these, nine fulfilled the histologic criteria of PPFE. Two patients were excluded because their upper lobe biopsy specimens showed marked interstitial inflammatory cell infiltrates within the intraalveolar fibrosis, and we found it difficult to completely rule out other interstitial pneumonia, such as connective tissue disease-related UIP. Accordingly, the nine patients meeting both radiologic and histologic criteria for PPFE comprised the final study group. The remaining 99 patients were given a diagnosis of IPF/UIP after multidisciplinary discussion among radiologists, pathologists, and pulmonologists. Clinical Findings in the Nine Patients With PPFE With UIP Pattern The clinical features of the nine patients (five men) with PPFE with UIP pattern are described in Table 1. Median age was 64 years (range, years) at the time of biopsy. Four patients died of respiratory failure between 24.3 and 42.7 months after the initial evaluation. Spontaneous pneumothorax or pneumomediastinum developed in six patients during the follow-up period. None of the patients had a significant history of anticancer drug therapy, radiotherapy, bone marrow transplantation, or connective tissue disorders. Biopsy specimens from multiple lobes were performed in the nine patients. The histology of all patients with PPFE with UIP pattern showed subpleural fibroelastosis and intraalveolar fibrosis in the upper lobes and UIP pattern in the lower lobes. Six had histologic UIP features along with PPFE in the upper lobes. Pleural fibrosis was present in two patients. Imaging and Histopathology of PPFE With UIP Pattern Chest HRCT images and histopathology of a typical case, patient 8, are shown in Figures 1 and 2. An HRCT image in the coronal plane showed bilateral dense subpleural consolidation. Upper lobe volume loss and hilar elevation were observed bilaterally. Less marked subpleural reticulation and ground glass opacities were observed in the lower lobes. Biopsy specimens from the upper lobe revealed subpleural fibroelastosis and abrupt transition from fibroelastosis to normal lung parenchyma, with no evidence of pleural fibrosis. A UIP pattern was seen in the lower lobe. TABLE 1 ] Clinical Characteristics in Nine Patients With PPFE With UIP Pattern Patient Characteristic Age, y Sex Male Female Male Female Male Male Male Female Female Symptoms Cough Cough Cough/DOE Cough Cough Check up DOE Cough DOE PT or PM PT PT PT/PM PM PT None None PT None Smoking history, pack-y 33 Never Never Never Never Never Family history Mother/aunt Sister None None None None None None Mother/sister Autoantibody None None None None None None None None None PFT Restrictive Restrictive Restrictive Restrictive Normal Normal Restrictive Restrictive Normal Survival, mo Outcome Alive Dead Dead Dead Dead Alive Alive Alive Alive DOE 5 dyspnea on exertion; PFT 5 pulmonary function test; PM 5 pneumomediastinum; PPFE 5 pleuroparenchymal fibroelastosis; PT 5 pneumothorax; UIP 5 usual interstitial pneumonia Original Research [ 146 # 5 CHEST NOVEMBER 2014 ]

4 Figure 1 High-resolution CT imaging of patient 8, a 65-y-old woman. A, Coronal image showing bilateral, apical, irregular pleural thickening. B, Subpleural thickening with fibrotic changes in the upper lobes. C, Less marked subpleural reticulation and ground glass opacities in the lower lobes. Clinical, Laboratory, and Radiologic Findings of PPFE With UIP Pattern Compared With IPF/UIP The clinical characteristics of the nine patients with PPFE with UIP pattern were compared with those of the 99 patients with IPF/UIP and are summarized in Table 2. Age, sex, and symptoms at initial consultation were not significantly different between the groups. Significant differences were observed in terms of BMI ( P,.01) and complication rates of pneumothorax or pneumomediastinum ( P 5.01) between the groups. These complications all occurred during the follow-up period. Radiologic findings in patients with PPFE with UIP pattern and those with IPF/UIP are shown in Table 3. The ratio of APDT to TDT was significantly lower in patients with PPFE with UIP pattern than in those with IPF/UIP ( P 5.04). The presence of honey combing was not significantly different between the groups. Physiologic testing indicated that % predicted diffusing capacity of lung for carbon monoxide was not decreased in the PPFE group in contrast to a significant decrease observed in the IPF group ( P,.01) (Table 4 ). Compared with the IPF group, the PPFE group showed Figure 2 Histopathologic findings in patient 8. A, A biopsy specimen from the upper lobe at low-power magnification shows subpleural fibroelastosis and abrupt transition from fibroelastosis to normal lung parenchyma (hematoxylin-eosin staining). B, A biopsy specimen from the upper lobe at high-power magnification shows an abundance of elastic fiber (elastic van Gieson staining); however, there was no evidence of pleural fibrosis. C and D, A biopsy specimen from the lower lobe at lowpower magnification (hematoxylineosin staining) (C) and high-power magnification (hematoxylin-eosin staining) (D) shows subpleural fibrosis and fibroblastic foci adjacent to established fibrosis. journal.publications.chestnet.org 1251

5 TABLE 2 ] Clinical Characteristics in Patients With PPFE With UIP Pattern and Those With IPF/UIP Characteristic PPFE With UIP Pattern (n 5 9) IPF/UIP (n 5 99) P Value Median age (range), y 64 (46-71) 67 (37-80).26 Male sex Smoking history.049 Never 5 23 Former and current, pack-y 4 (18 12) 76 (41 28) BMI, kg/m ,.01 Initial symptoms Cough DOE DOE and cough No symptoms Clubbing PT/PM Acute exacerbation Data are presented as counts or mean SD unless otherwise indicated. IPF 5 idiopathic pulmonary fibrosis. See Table 1 legend for expansion of other abbreviations. higher residual volume (RV) and ratio of RV to total lung capacity (TLC). The PPFE group also showed significantly higher Pa co 2 (P 5.04). In contrast, alveolararterial oxygen tension differences were within the normal range in the PPFE group. The PPFE group had lower levels of serum biomarkers, such as Krebs von den Lungen-6, than the IPF group. BAL fluid yielded lower cell counts in the PPFE group. No significant difference was found between groups in cell fraction and the CD4/ CD8 ratio. Survival Analysis of PPFE With UIP Pattern and IPF/UIP Survival analysis in patients with PPFE with UIP pattern compared with patients with IPF/UIP is shown in Figure 3. The median survival time was 31.5 and 82.1 months, respectively. Although the survival time tended to be shorter in the PPFE group, the difference was not significant ( P 5.13). Discussion To our knowledge, this study is the first to describe the clinical characteristics of PPFE with UIP pattern compared with IPF/UIP. We identified nine patients with PPFE with UIP pattern among 110 consecutive patients with surgically proven IPF/UIP diagnosed according to the 2002 ATS/ERS statement. 18 We identified three characteristic features of PPFE with UIP pattern. Compared with patients with IPF/UIP, patients with PPFE with UIP pattern had (1) a higher complication rate of pneumothorax or pneumomediastinum and lower BMI; (2) a flattened chest (ie, lower APDT/TDT ratio); and (3) distinct features of pulmonary function in the form of restrictive pattern and alveolar hypoventilation, including TABLE 3 ] Radiologic Findings of Patients With PPFE With UIP Pattern and Those of IPF/UIP Characteristic PPFE With UIP Pattern (n 5 9) IPF/UIP (n 5 99) P Value Image nding Dense subpleural consolidation 9 30,.01 Honeycombing Thoracic dimensions APDT, cm ,.01 TDT, cm APDT/TDT, % Data are presented as counts or mean SD. APDT 5 anteroposterior diameter of the thorax; TDT 5 transverse diameter of the thorax. See Table 1 and 2 legends for expansion of other abbreviations Original Research [ 146 # 5 CHEST NOVEMBER 2014 ]

6 TABLE 4 ] Pulmonary Function, Arterial Blood Gas Analysis, Laboratory Data, and BAL Fluid Findings in Patients With PPFE With UIP Pattern and Those With IPF/UIP Parameter PPFE With UIP Pattern (n 5 9) IPF/UIP (n 5 99) P Value Pulmonary function FVC, % predicted FEV 1, % predicted FEV 1 /FVC ratio D LCO, ml/min/mm Hg D LCO, % predicted ,.01 D LCO /V A, ml/min/mm Hg/L D LCO /V A, % predicted TLC, % predicted RV, L ,.01 RV/TLC, % ,.01 Blood gas test ph Pa O 2, mm Hg Pa CO 2, mm Hg P( A -a) O 2, mm Hg ,.01 Laboratory data LDH, International Units/L KL-6, International Units/mL ,.01 SP-D, ng/ml BAL uid ndings Cell count, /ml ,.01 Macrophages, % Neutrophils, % Lymphocytes, % Eosinophils, % CD4/CD8 ratio Data are presented as mean SD. D LCO 5 diffusing capacity of lung for carbon monoxide; KL-6 5 Krebs von den Lungen-6; LDH 5 lactate dehydrogenase; P( A -a) O 2 5 alveolar-arterial oxygen tension difference; RV 5 residual volume; SP-D 5 surfactant protein-d; TLC 5 total lung capacity; V A 5 alveolar volume. See Table 1 and 2 legends for expansion of other abbreviations. an increased RV/TLC ratio and Pa co 2. The results define the clinical and radiologic characteristics of PPFE with UIP pattern and support the view that PPFE with UIP pattern is a disease entity distinct from IPF/UIP. A higher complication rate of pneumothorax or pneumomediastinum in the PPFE group was consistent with the results of previously published reports. 1,2,4,11,12,16 It is true that findings similar to PPFE could be observed as sequelae of ordinary spontaneous pneumothorax. However, all the patients experienced pneumothorax or pneumomediastinum after the initial visit, and it is unlikely that the pneumothorax caused PPFE. Flattened chest is a characteristic finding in idiopathic pulmonary upper lobe fibrosis and PPFE in the literature. 2,13 It is also reported that the thoracic cage becomes flattened in the progression of PPFE. 19,20 The present study showed that the APDT/TDT ratio and APDT in the PPFE group were lower than those in the IPF group. In addition, despite the PPFE group having upper lobe volume loss, TLC was increased in the PPFE group compared with the IPF group. These results imply that upper lobe volume loss led to flattened chest and the compensatory hyperinflation of the middle and lower lobes in the PPFE group. Respiratory function in PPFE with UIP pattern was characterized by a restrictive pattern and alveolar hypoventilation, journal.publications.chestnet.org 1253

7 The histopathologic features of PPFE, such as intraalveolar fibrosis and elastosis, correspond to the presence of an apical cap. 24,25 Patients with PPFE with UIP pattern showed dense subpleural consolidation with more diffuse distribution in biopsy specimens not from the apex but mainly from the posterior segment in which apical cap is not usually observed. In addition, we confirmed progressive upper lobe volume loss in some patients, which is inconsistent with the natural course of the apical cap. Figure 3 Kaplan-Meier distribution of survival time in patients with PPFE with UIP pattern vs those with IPF/UIP. IPF 5 idiopathic pulmonary fibrosis; PPFE 5 pleuroparenchymal fibroelastosis; UIP 5 usual interstitial pneumonia. as indicated by the increased RV/TLC ratio and Pa co 2. Although both the IPF and the PPFE groups showed a restrictive pattern, some differences existed. In the IPF group both TLC and RV were decreased as expected. In the PPFE group, however, TLC was somewhat decreased, whereas RV was increased. Because this type of restrictive change is common in patients with neuromuscular disorders or pleural diseases, there is a strong possibility that lung movement is being restricted in patients with PPFE with UIP pattern. In this study, none of the patients had neuromuscular or neurologic complications. It is possible that pleural and subpleural thickening causes restricted lung movement in patients with PPFE with UIP pattern, resulting in alveolar hypoventilation. The survival time tended to be shorter in patients with PPFE with UIP pattern than in patients with IPF/UIP. In the four patients who died, the cause of death was chronic respiratory failure with recurrent pneumothorax or pneumomediastinum; the incidence of pneumothorax or pneumomediastinum was significantly higher in the PPFE group. Pneumothorax in patients with IPF/UIP is reportedly associated with rapid deterioration on HRCT imaging 21 and poor prognosis. 22 Moreover, the PPFE group had a lower BMI than the IPF group. Low BMI at IPF diagnosis has been associated with poor prognosis. 23 The present observation of poorer survival outcome in the PPFE group can be explained in the same way. In the present study, the clinical and radiologic features of PPFE with UIP pattern were similar to those previously reported for PPFE. In the 2011 ATS/ERS/ Japanese Respiratory Society/Latin American Thoracic Association statement, 17 upper or mid-lung-predominant distribution is one of the seven features of inconsistent with UIP on HRCT imaging. PPFE with UIP pattern has been judged inconsistent with UIP on HRCT imaging and as UIP by histopathologic analysis and then considered possible IPF. A certain number of patients with this disease may have been given a diagnosis of IPF/UIP. In a recently published ATS/ERS statement on the classification of idiopathic interstitial pneumonias, PPFE was mentioned for the first time, to our knowledge, as a rare form of independent idiopathic interstitial pneumonia. 26 Th e present results show that the characteristics of PPFE with UIP pattern more closely resemble those previously reported for PPFE than those for IPF/UIP and support the idea that this disease is distinct from IPF/UIP and classifiable as PPFE. This study has several limitations. It was a singlecenter retrospective study, and the number of patients with PPFE with UIP pattern was small. However, PPFE is a rare form of interstitial lung disease, and, thus, prospective studies will prove difficult. Moreover, the patients with IPF/UIP in this study had a longer survival time compared with previous reports. 17 A possible reason is that the present study only included patients able to undergo surgical lung biopsy; therefore, the survival result for IPF/UIP may exclude the more severe cases. In conclusion, the results support the view that PPFE with UIP pattern is a disease entity distinct from IPF/UIP. It may well be classified as PPFE rather than UIP Original Research [ 146 # 5 CHEST NOVEMBER 2014 ]

8 Acknowledgments Author contributions: T. Oda had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. T. Ogura contributed to the study concept and design, data analysis and interpretation, and final approval of the manuscript; H. K. and Y. H. contributed to the study concept and design and submission of the manuscript; E. H. contributed to the data collection, organization, and analysis and preparation, review, writing, and submission of the manuscript; and T. B., Y. E., T. I., K. O., T. T., and F. S. contributed to the data collection, organization, and analysis and preparation, review, and submission of the manuscript. Financial/nonfinancial disclosures: The authors have reported to CHEST that no potential conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article. Role of sponsors: The sponsor had no role in the design of the study, the collection and analysis of the data, or the preparation of the manuscript. Others contributions: Editorial assistance was provided by Stephen L. Nishimura, PhD, Department of Pathology, University of California, San Francisco, California. References 1. Frankel SK, Cool CD, Lynch DA, Brown KK. Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest ;126(6): Amitani R, Niimi A, Kuze F. Idiopathic pulmonary upper lobe fibrosis [in Japanese]. Kokyu ; 11 ( 6 ): Kobayashi Y, Sakurai M, Kushiya M, et al. Idiopathic pulmonary fibrosis of the upper lobe: a case report [in Japanese]. Nihon Kokyuki Gakkai Zasshi ;37(10): Shiota S, Shimizu K, Suzuki M, et al. Seven cases of marked pulmonary fibrosis in the upper lobe [in Japanese]. Nihon Kokyuki Gakkai Zasshi ;37(2): Azoulay E, Paugam B, Heymann MF, et al. Familial extensive idiopathic bilateral pleural fibrosis. Eur Respir J ;14(4): Becker CD, Gil J, Padilla ML. Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity? Mod Pathol ;21(6): Nei T, Kawamoto M, Satoh E, et al. A case of suspected idiopathic pulmonary upper lobe fibrosis (Amitani disease) with acute exacerbation [in Japanese]. Nihon Kokyuki Gakkai Zasshi ;47(2): Morimoto A, Mochizuki Y, Nakahara Y, Kawamura T, Sakaki S, Kobashi Y. Case of idiopathic pulmonary upper lobe fibrosis [in Japanese]. Nihon Kokyuki Gakkai Zasshi ;48(12): von der Thüsen JH, Hansell DM, Tominaga M, et al. Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation. Mod Pathol ;24(12): Piciucchi S, Tomassetti S, Casoni G, et al. High resolution CT and histological findings in idiopathic pleuroparenchymal fibroelastosis: features and differential diagnosis. Respir Res ; 12 ( 1 ): Watanabe K, Nagata N, Kitasato Y, et al. Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis. Respir Investig ;50(3): Kusagaya H, Nakamura Y, Kono M, et al. Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients. BMC Pulm Med ;12: Iesato K, Ogasawara T, Masuda A, et al. Idiopathic pulmonary upper lobe fibrosis; clinical and pathological features [in Japanese]. Rinsho Hoshasen ;50(1): Flaherty KR, Travis WD, Colby TV, et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med ;164(9): Monaghan H, Wells AU, Colby TV, du Bois RM, Hansell DM, Nicholson AG. Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest ; 125 ( 2 ): Reddy TL, Tominaga M, Hansell DM, et al. Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J ;40(2): Raghu G, Collard HR, Egan JJ, et al ; ATS/ ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med ; 183 (6): American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June and by the ERS Executive Committee, June Am J Respir Crit Care Med ;165(2): Harada T, Yoshida Y, Kitasato Y, et al. The thoracic cage becomes flattened in the progression of pleuroparenchymal fibroelastosis. Eur Respir Rev. 2014;23(132): Watanabe K. Pleuroparenchymal fibroelastosis: its clinical characteristics. Curr Respir Med Rev ;9: Iwasawa T, Ogura T, Takahashi H, et al. Pneumothorax and idiopathic pulmonary fibrosis. Jpn J Radiol ;28(9): Picado C, Gómez de Almeida R, Xaubet A, Montserrat J, Letang E, Sánchez-Lloret J. Spontaneous pneumothorax in cryptogenic fibrosing alveolitis. Respiration ;48(1): Kim JH, Lee JH, Ryu YJ, Chang JH. Clinical predictors of survival in idiopathic pulmonary fibrosis. Tuberc Respir Dis (Seoul) ;73(3): Butler C II, Kleinerman J. The pulmonary apical cap. Am J Pathol ; 60 ( 2 ): Yousem SA. Pulmonary apical cap: a distinctive but poorly recognized lesion in pulmonary surgical pathology. Am J Surg Pathol ; 25 ( 5 ): Travis WD, Costabel U, Hansell DM, et al ; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med ;188(6): journal.publications.chestnet.org 1255

A Patient with Idiopathic Pleuroparenchymal Fibroelastosis Showing a Sustained Pulmonary Function due to Treatment with Pirfenidone

A Patient with Idiopathic Pleuroparenchymal Fibroelastosis Showing a Sustained Pulmonary Function due to Treatment with Pirfenidone CASE REPORT A Patient with Idiopathic Pleuroparenchymal Fibroelastosis Showing a Sustained Pulmonary Function due to Treatment with Pirfenidone Seidai Sato 1, Masaki Hanibuchi 1, Mikiko Takahashi 2, Yuh

More information

Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients

Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients Kusagaya et al. BMC Pulmonary Medicine 2012, 12:72 RESEARCH ARTICLE Open Access Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients

More information

Diffuse Interstitial Lung Diseases: Is There Really Anything New?

Diffuse Interstitial Lung Diseases: Is There Really Anything New? : Is There Really Anything New? Sujal R. Desai, MBBS, MD ESTI SPEAKER SUNDAY Society of Thoracic Radiology San Antonio, Texas March 2014 Diffuse Interstitial Lung Disease The State of Play DILDs Is There

More information

Differential diagnosis

Differential diagnosis Differential diagnosis Idiopathic pulmonary fibrosis (IPF) is part of a large family of idiopathic interstitial pneumonias (IIP), one of four subgroups of interstitial lung disease (ILD). Differential

More information

Imaging: how to recognise idiopathic pulmonary fibrosis

Imaging: how to recognise idiopathic pulmonary fibrosis REVIEW IDIOPATHIC PULMONARY FIBROSIS Imaging: how to recognise idiopathic pulmonary fibrosis Anand Devaraj Affiliations: Dept of Radiology, St George s Hospital, London, UK. Correspondence: Anand Devaraj,

More information

CTD-related Lung Disease

CTD-related Lung Disease 13 th Cambridge Chest Meeting King s College, Cambridge April 2015 Imaging of CTD-related Lung Disease Dr Sujal R Desai King s College Hospital, London Disclosure Statement No Disclosures / Conflicts of

More information

Progress in Idiopathic Pulmonary Fibrosis

Progress in Idiopathic Pulmonary Fibrosis Progress in Idiopathic Pulmonary Fibrosis David A. Lynch, MB Disclosures Progress in Idiopathic Pulmonary Fibrosis David A Lynch, MB Consultant: t Research support: Perceptive Imaging Boehringer Ingelheim

More information

Monday 10 September Interstitial lung disease 15:10 15:35. The uncommon interstitial lung diseases (ILD)

Monday 10 September Interstitial lung disease 15:10 15:35. The uncommon interstitial lung diseases (ILD) Interstitial lung disease 15:10 15:35 The uncommon interstitial lung diseases (ILD) Dr Grant Griffiths, Cwm Taf University Health Board, Cardiff Be familiar with the Diagnostic criteria for idiopathic

More information

5/9/2015. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. No, I am not a pulmonologist! Radiology

5/9/2015. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. No, I am not a pulmonologist! Radiology Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective No, I am not a pulmonologist! Radiology Pathology Clinical 1 Everyone needs a CT Confidence in diagnosis Definitive HRCT +

More information

11/10/2014. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. Radiology

11/10/2014. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. Radiology Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective Radiology Pathology Clinical 1 Role of HRCT Diagnosis Fibrosis vs. inflammation Next step in management Response to treatment

More information

Non-neoplastic Lung Disease II

Non-neoplastic Lung Disease II Pathobasic Non-neoplastic Lung Disease II Spasenija Savic Prince Pathology Program Systematic approach to surgical lung biopsies with ILD Examples (chronic ILD): Idiopathic interstitial pneumonias: UIP,

More information

Idiopathic Pleuroparenchymal Fibroelastosis

Idiopathic Pleuroparenchymal Fibroelastosis Curr Pulmonol Rep (2017) 6:9 15 DOI 10.1007/s13665-017-0160-5 NUTRITION AND CLINICAL CARE (J PATEL, SECTION EDITOR) Idiopathic Pleuroparenchymal Fibroelastosis Martina Bonifazi 1,2 & M. Angeles Montero

More information

Usual Interstitial pneumonia and Nonspecific Interstitial Pneumonia. Nitra and the Gangs.

Usual Interstitial pneumonia and Nonspecific Interstitial Pneumonia. Nitra and the Gangs. Usual Interstitial pneumonia and Nonspecific Interstitial Pneumonia Nitra and the Gangs. บทน ำและบทท ๓, ๑๐, ๑๒, ๑๓, ๑๔, ๑๕, ๑๗ Usual Interstitial Pneumonia (UIP) Most common & basic pathologic pattern

More information

Liebow and Carrington's original classification of IIP

Liebow and Carrington's original classification of IIP Liebow and Carrington's original classification of IIP-- 1969 Eric J. Stern MD University of Washington UIP Usual interstitial pneumonia DIP Desquamative interstitial pneumonia BIP Bronchiolitis obliterans

More information

Combined Unclassifiable Interstitial Pneumonia and Emphysema: A Report of Two Cases

Combined Unclassifiable Interstitial Pneumonia and Emphysema: A Report of Two Cases CASE REPORT Combined Unclassifiable Interstitial Pneumonia and Emphysema: A Report of Two Cases Nobuhiko Nagata 1, Kentaro Watanabe 2, Michihiro Yoshimi 3, Hiroshi Okabayashi 4, Katsuo Sueishi 5, Kentaro

More information

Outline Definition of Terms: Lexicon. Traction Bronchiectasis

Outline Definition of Terms: Lexicon. Traction Bronchiectasis HRCT OF IDIOPATHIC INTERSTITIAL PNEUMONIAS Disclosures Genentech, Inc. Speakers Bureau Tadashi Allen, MD University of Minnesota Assistant Professor Diagnostic Radiology 10/29/2016 Outline Definition of

More information

Cryptogenic Organizing Pneumonia Diagnosis Approach Based on a Clinical-Radiologic-Pathologic Consensus

Cryptogenic Organizing Pneumonia Diagnosis Approach Based on a Clinical-Radiologic-Pathologic Consensus Cryptogenic Organizing Pneumonia Diagnosis Approach Based on a Clinical-Radiologic-Pathologic Consensus Poster No.: C-1622 Congress: ECR 2012 Type: Scientific Exhibit Authors: C. Cordero Lares, E. Zorita

More information

4/17/2010 C ini n ca c l a Ev E a v l a ua u t a ion o n of o ILD U dat a e t e i n I LDs

4/17/2010 C ini n ca c l a Ev E a v l a ua u t a ion o n of o ILD U dat a e t e i n I LDs Update in ILDs Diagnosis 101: Clinical Evaluation April 17, 2010 Jay H. Ryu, MD Mayo Clinic, Rochester MN Clinical Evaluation of ILD Outline General aspects of ILDs Classification of ILDs Clinical evaluation

More information

NONE OVERVIEW FINANCIAL DISCLOSURES UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF (UIP) FOR PATHOLOGISTS. IPF = Idiopathic UIP Radiologic UIP Path UIP

NONE OVERVIEW FINANCIAL DISCLOSURES UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF (UIP) FOR PATHOLOGISTS. IPF = Idiopathic UIP Radiologic UIP Path UIP UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF () FOR PATHOLOGISTS Thomas V. Colby, M.D. Professor of Pathology (Emeritus) Mayo Clinic Arizona FINANCIAL DISCLOSURES NONE OVERVIEW IPF Radiologic Dx Pathologic

More information

DIAGNOSTIC NOTE TEMPLATE

DIAGNOSTIC NOTE TEMPLATE DIAGNOSTIC NOTE TEMPLATE SOAP NOTE TEMPLATE WHEN CONSIDERING A DIAGNOSIS OF IDIOPATHIC PULMONARY FIBROSIS (IPF) CHIEF COMPLAINT HISTORY OF PRESENT ILLNESS Consider IPF as possible diagnosis if any of the

More information

Acute Exacerbation of Usual Interstitial Pneumonia After Resection of Lung Cancer

Acute Exacerbation of Usual Interstitial Pneumonia After Resection of Lung Cancer Acute Exacerbation of Usual Interstitial Pneumonia After Resection of Lung Cancer Hiroaki Sugiura, MD, Atsuya Takeda, MD, PhD, Toshiko Hoshi, MD, PhD, Yoshinori Kawabata, MD, Koichi Sayama, MD, PhD, Masahiro

More information

Diagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines

Diagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines Diagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines Rebecca Keith, MD Assistant Professor, Division of Pulmonary and Critical Care Medicine National Jewish Health, Denver, CO Objectives

More information

Original Article. Keywords: Systemic sclerosis (SSc); mixed connective tissue disease (MCTD); interstitial lung disease (ILD); biomarker

Original Article. Keywords: Systemic sclerosis (SSc); mixed connective tissue disease (MCTD); interstitial lung disease (ILD); biomarker Original Article Serum KL-6 and surfactant protein-d as monitoring and predictive markers of interstitial lung disease in patients with systemic sclerosis and mixed connective tissue disease Hideaki Yamakawa

More information

INTERSTITIAL LUNG DISEASE. Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018

INTERSTITIAL LUNG DISEASE. Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018 INTERSTITIAL LUNG DISEASE Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018 Interstitial Lung Disease Interstitial Lung Disease Prevalence by Diagnosis: Idiopathic Interstitial

More information

Case Presentations in ILD. Harold R. Collard, MD Department of Medicine University of California San Francisco

Case Presentations in ILD. Harold R. Collard, MD Department of Medicine University of California San Francisco Case Presentations in ILD Harold R. Collard, MD Department of Medicine University of California San Francisco Outline Overview of diagnosis in ILD Definition/Classification High-resolution CT scan Multidisciplinary

More information

TBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than

TBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than TBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than PAP) BAL is not required as a diagnostic tool in patients

More information

Challenges in the Diagnosis of Interstitial Lung Disease

Challenges in the Diagnosis of Interstitial Lung Disease Challenges in the Diagnosis of Interstitial Lung Disease Kirk D. Jones, MD UCSF Dept. of Pathology kirk.jones@ucsf.edu Overview New Classification of IIP Prior classification Modifications for new classification

More information

Bronchoalveolar Lavage and Histopathologic Diagnosis Based on Biopsy

Bronchoalveolar Lavage and Histopathologic Diagnosis Based on Biopsy Idiopathic Pulmonary Fibrosis Bronchoalveolar Lavage and Histopathologic Diagnosis Based on Biopsy JMAJ 46(11): 469 474, 2003 Yukihiko SUGIYAMA Professor, Division of Pulmonary Medicine, Department of

More information

Influence of Smoking in Interstitial Pneumonia Presenting with a Non-Specific Interstitial Pneumonia Pattern

Influence of Smoking in Interstitial Pneumonia Presenting with a Non-Specific Interstitial Pneumonia Pattern ORIGINAL ARTICLE Influence of Smoking in Interstitial Pneumonia Presenting with a Non-Specific Interstitial Pneumonia Pattern Tetsuro Sawata, Masashi Bando, Masayuki Nakayama, Naoko Mato, Hideaki Yamasawa

More information

Lung Allograft Dysfunction

Lung Allograft Dysfunction Lung Allograft Dysfunction Carlos S. Restrepo M.D. Ameya Baxi M.D. Department of Radiology University of Texas Health San Antonio Disclaimer: We do not have any conflict of interest or financial gain to

More information

International consensus statement on idiopathic pulmonary fibrosis

International consensus statement on idiopathic pulmonary fibrosis Eur Respir J 2001; 17: 163 167 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2001 European Respiratory Journal ISSN 0903-1936 PERSPECTIVE International consensus statement on idiopathic

More information

The radiological differential diagnosis of the UIP pattern

The radiological differential diagnosis of the UIP pattern 5th International Conference on Idiopathic Pulmonary Fibrosis, Modena, 2015, June 12th The radiological differential diagnosis of the UIP pattern Simon Walsh King s College Hospital Foundation Trust London,

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Idiopathic Pulmonary Fibrosis Page 1 of 10 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Idiopathic Pulmonary Fibrosis (Esbriet /pirfenidone, Ofev /nintedanib)

More information

Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparison of the clinicopathologic features and prognosis

Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparison of the clinicopathologic features and prognosis Original Article Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparison of the clinicopathologic features and prognosis Xia Li 1, Chang Chen 2, Jinfu Xu 1, Jinming Liu 1, Xianghua

More information

Challenges in the Diagnosis of Interstitial Lung Disease

Challenges in the Diagnosis of Interstitial Lung Disease Challenges in the Diagnosis of Interstitial Lung Disease Kirk D. Jones, MD UCSF Dept. of Pathology kirk.jones@ucsf.edu Overview New Classification of IIP Prior classification Modifications for new classification

More information

Interstitial Pneumonia Related to Undifferentiated Connective Tissue Disease Pathologic Pattern and Prognosis

Interstitial Pneumonia Related to Undifferentiated Connective Tissue Disease Pathologic Pattern and Prognosis [ Original Research Diffuse Lung Disease ] Interstitial Pneumonia Related to Undifferentiated Connective Tissue Disease Pathologic Pattern and Prognosis Ho-Cheol Kim, MD ; Wonjun Ji, MD ; Mi Young Kim,

More information

Criteria for confident HRCT diagnosis of usual interstitial pneumonia (UIP)

Criteria for confident HRCT diagnosis of usual interstitial pneumonia (UIP) Criteria for confident HRCT diagnosis of usual interstitial pneumonia (UIP) Assem El Essawy (1) & Amr A. Nassef (٢) Abstract Identification of interstitial pneumonia (IP) was mainly based on histological

More information

Radiologic pathologic discordance in biopsy-proven usual interstitial pneumonia

Radiologic pathologic discordance in biopsy-proven usual interstitial pneumonia ERJ Express. Published on February 25, 2016 as doi: 10.1183/13993003.01680-2015 ORIGINAL ARTICLE IN PRESS CORRECTED PROOF Radiologic pathologic discordance in biopsy-proven usual interstitial pneumonia

More information

Case 4 History. 58 yo man presented with prox IP joint swelling 2 months later pain and swelling in multiple joints Chest radiograph: bi-basilar

Case 4 History. 58 yo man presented with prox IP joint swelling 2 months later pain and swelling in multiple joints Chest radiograph: bi-basilar Case 4 History 58 yo man presented with prox IP joint swelling 2 months later pain and swelling in multiple joints Chest radiograph: bi-basilar basilar infiltrates suggestive of pulmonary fibrosis Open

More information

Key words: CT scanners; interstitial lung diseases; polymyositis-dermatomyositis; x-ray

Key words: CT scanners; interstitial lung diseases; polymyositis-dermatomyositis; x-ray Nonspecific Interstitial Pneumonia Associated With Polymyositis and Dermatomyositis* Serial High-Resolution CT Findings and Functional Correlation Hiroaki Arakawa, MD; Hidehiro Yamada, MD; Yasuyuki Kurihara,

More information

Diagnostic challenges in IPF

Diagnostic challenges in IPF Medicine, Nursing and Health Sciences Diagnostic challenges in IPF Dr Ian Glaspole Central and Eastern Clinical School, Alfred Hospital and Monash University March 2015 Disclosures Consultancy fees from

More information

A Review of Interstitial Lung Diseases. Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco

A Review of Interstitial Lung Diseases. Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco A Review of Interstitial Lung Diseases Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco Outline Overview of diagnosis in ILD Why it is important Definition/Classification

More information

ARTICLE IN PRESS. Ahuva Grubstein a, Daniele Bendayan b, Ithak Schactman c, Maya Cohen a, David Shitrit b, Mordechai R. Kramer b,

ARTICLE IN PRESS. Ahuva Grubstein a, Daniele Bendayan b, Ithak Schactman c, Maya Cohen a, David Shitrit b, Mordechai R. Kramer b, Respiratory Medicine (2005) 99, 948 954 Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature

More information

Connective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates

Connective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates Connective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates Maria Elena Vega, M.D Assistant Professor of Medicine Lewis Katz School of Medicine at Temple University Nothing to

More information

An earlier and more confident diagnosis of idiopathic pulmonary fibrosis

An earlier and more confident diagnosis of idiopathic pulmonary fibrosis Eur Respir Rev 2012; 21: 124, 141 146 DOI: 10.1183/09059180.00000812 CopyrightßERS 2012 REVIEW: IPF An earlier and more confident diagnosis of idiopathic pulmonary fibrosis Roland M. du Bois ABSTRACT:

More information

Clinico-radiological features and efficacy of anti-fibrotic agents in atypical idiopathic pulmonary fibrosis

Clinico-radiological features and efficacy of anti-fibrotic agents in atypical idiopathic pulmonary fibrosis Original Article Clinico-radiological features and efficacy of anti-fibrotic agents in atypical idiopathic pulmonary fibrosis Keishi Sugino 1, Hiroshige Shimizu 1, Yasuhiko Nakamura 1, Takuma Isshiki 1,

More information

Financial disclosure COMMON DIAGNOSES IN HRCT. High Res Chest HRCT. HRCT Pre test. I have no financial relationships to disclose. Anatomy Nomenclature

Financial disclosure COMMON DIAGNOSES IN HRCT. High Res Chest HRCT. HRCT Pre test. I have no financial relationships to disclose. Anatomy Nomenclature Financial disclosure I have no financial relationships to disclose. Douglas Johnson D.O. Cardiothoracic Imaging Gaston Radiology COMMON DIAGNOSES IN HRCT High Res Chest Anatomy Nomenclature HRCT Sampling

More information

HRCT in Diffuse Interstitial Lung Disease Steps in High Resolution CT Diagnosis. Where are the lymphatics? Anatomic distribution

HRCT in Diffuse Interstitial Lung Disease Steps in High Resolution CT Diagnosis. Where are the lymphatics? Anatomic distribution Steps in High Resolution CT Diagnosis Pattern of abnormality Distribution of disease Associated findings Clinical history Tomás Franquet MD What is the diagnosis? Hospital de Sant Pau. Barcelona Secondary

More information

IPF: Epidemiologia e stato dell arte

IPF: Epidemiologia e stato dell arte IPF: Epidemiologia e stato dell arte Clinical Classification Diffuse parenchimal lung diseases Exposure-related: - occupational - environmental - medication Desquamative interstitial pneumonia Idiopathic

More information

A Review of Interstitial Lung Diseases

A Review of Interstitial Lung Diseases Outline A Review of Interstitial Lung Diseases Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco Overview of diagnosis in ILD Why it is important Definition/Classification

More information

Diffuse interstitial lung diseases (DILDs) are a heterogeneous group of non-neoplastic, noninfectious

Diffuse interstitial lung diseases (DILDs) are a heterogeneous group of non-neoplastic, noninfectious Focused Issue of This Month Diagnostic Approaches to Diffuse Interstitial Lung Diseases Dong Soon Kim, MD Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine E -

More information

Thoracic lung involvement in rheumatoid arthritis: Findings on HRCT

Thoracic lung involvement in rheumatoid arthritis: Findings on HRCT Thoracic lung involvement in rheumatoid arthritis: Findings on HRCT Poster No.: C-2488 Congress: ECR 2015 Type: Educational Exhibit Authors: R. E. Correa Soto, M. J. Martín Sánchez, J. M. Fernandez 1 1

More information

Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis

Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis JULIE A. BJORAKER, JAY H. RYU, MARK K. EDWIN, JEFFREY L. MYERS, HENRY D. TAZELAAR, DARRELL R. SCHROEDER, and KENNETH

More information

Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias

Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias Respiratory Medicine (2007) 101, 655 660 Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias Yon Ju Ryu a, Man Pyo Chung b,, Joungho Han c, Tae Sung Kim d, Kyung Soo Lee d, Eun-Mi Chun

More information

UIP Possibile e Probabile

UIP Possibile e Probabile UIP Possibile e Probabile Sergio Harari U.O. di Pneumologia e UTIR Servizio di Emodinamica e Fisiopatologia Respiratoria Ospedale San Giuseppe - Milano Current definition of IPF IPF is a distinct type

More information

June 2013 Pulmonary Case of the Month: Diagnosis Makes a Difference. Lewis J. Wesselius, MD 1 Henry D. Tazelaar, MD 2

June 2013 Pulmonary Case of the Month: Diagnosis Makes a Difference. Lewis J. Wesselius, MD 1 Henry D. Tazelaar, MD 2 June 2013 Pulmonary Case of the Month: Diagnosis Makes a Difference Lewis J. Wesselius, MD 1 Henry D. Tazelaar, MD 2 Departments of Pulmonary Medicine 1 and Laboratory Medicine and Pathology 2 Mayo Clinic

More information

A case of a patient with IPF treated with nintedanib. Prof. Kreuter and Prof. Heussel

A case of a patient with IPF treated with nintedanib. Prof. Kreuter and Prof. Heussel A case of a patient with IPF treated with nintedanib Prof. Kreuter and Prof. Heussel Case Overview This case describes the history of a patient with IPF who, at the time of diagnosis, had symptoms typical

More information

INTERSTITIAL LUNG DISEASES: FOCUS ON IDIOPATHIC PULMONARY FIBROSIS (IPF)

INTERSTITIAL LUNG DISEASES: FOCUS ON IDIOPATHIC PULMONARY FIBROSIS (IPF) INTERSTITIAL LUNG DISEASES: FOCUS ON IDIOPATHIC PULMONARY FIBROSIS (IPF) Marilyn K. Glassberg Csete, M.D. Professor of Medicine, Surgery, and Pediatrics Director, Interstitial and Rare Lung Disease Program

More information

Clinical characteristics of idiopathic pulmonary fibrosis patients according to their smoking status

Clinical characteristics of idiopathic pulmonary fibrosis patients according to their smoking status Original Article Clinical characteristics of idiopathic pulmonary fibrosis patients according to their smoking status Tomoo Kishaba, Hiroaki Nagano, Yuichiro Nei, Shin Yamashiro Department of Respiratory

More information

INVITED REVIEW SERIES: PULMONARY FIBROSIS SERIES EDITORS: MARTIN KOLB AND GERARD COX

INVITED REVIEW SERIES: PULMONARY FIBROSIS SERIES EDITORS: MARTIN KOLB AND GERARD COX INVITED REVIEW SERIES: PULMONARY FIBROSIS SERIES EDITORS: MARTIN KOLB AND GERARD COX Diagnosing fibrotic lung disease: When is high-resolution computed tomography sufficient to make a diagnosis of idiopathic

More information

Idiopathic interstitial pneumonias (IIPs) are a group of

Idiopathic interstitial pneumonias (IIPs) are a group of SYMPOSIA C. Isabela S. Silva, MD, PhD and Nestor L. Müller, MD, PhD Abstract: The idiopathic interstitial pneumonias (IIPs) are a group of diffuse parenchymal lung diseases of unknown etiology characterized

More information

Idiopathic Pulmonary of Care

Idiopathic Pulmonary of Care Chapter 6.1 Living Medical etextbook A Digital Tool at the Point of Care From Projects In Knowledge Pulmonology Idiopathic Pulmonary Fibrosis @Point of Care IPF Case Study: Typical Presentation, Role of

More information

The Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (2), Page

The Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (2), Page The Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (2), Page 1135-1140 Role of High Resolution Computed Tomography in Diagnosis of Interstitial Lung Diseases in Patients with Collagen Diseases

More information

USEFULNESS OF HRCT IN DIAGNOSIS AND FOLLOW UP OF PULMONARY INVOLVEMENT IN SYSTEMIC SCLEROSIS

USEFULNESS OF HRCT IN DIAGNOSIS AND FOLLOW UP OF PULMONARY INVOLVEMENT IN SYSTEMIC SCLEROSIS USEFULNESS OF HRCT IN DIAGNOSIS AND FOLLOW UP OF PULMONARY INVOLVEMENT IN SYSTEMIC SCLEROSIS Brestas P., Vergadis V., Emmanouil E., Malagari K. 2 nd Dept of Radiology, University of Athens, Greece ABSTRACT

More information

Body mass index percent forced vital capacity respiratory hospitalization: new staging for idiopathic pulmonary fibrosis patients

Body mass index percent forced vital capacity respiratory hospitalization: new staging for idiopathic pulmonary fibrosis patients Original Article Body mass index percent forced vital capacity respiratory hospitalization: new staging for idiopathic pulmonary fibrosis patients Tomoo Kishaba, Hiroaki Nagano, Yuichiro Nei, Shin Yamashiro

More information

Patient with FVC>90% predicted. Demosthenes Bouros, Vasilios Tzilas University of Athens

Patient with FVC>90% predicted. Demosthenes Bouros, Vasilios Tzilas University of Athens Patient with FVC>90% predicted Demosthenes Bouros, Vasilios Tzilas University of Athens CASE OVERVIEW A 63-year-old, male patient with progressive exertional dyspnoea lasting for 2 years and dry cough

More information

OFEV MEDIA BACKGROUNDER

OFEV MEDIA BACKGROUNDER OFEV MEDIA BACKGROUNDER 1 What is OFEV (nintedanib*)? 2 How does OFEV (nintedanib*) work? 3 Data overview 4 OFEV (nintedanib*) approval status 1 What is OFEV (nintedanib*)? OFEV (nintedanib*) is a small

More information

Patient with IPF and no honeycombing on HRCT. Case 1 Demosthenes Bouros, Vasilios Tzilas University of Athens

Patient with IPF and no honeycombing on HRCT. Case 1 Demosthenes Bouros, Vasilios Tzilas University of Athens Patient with IPF and no honeycombing on HRCT Case 1 Demosthenes Bouros, Vasilios Tzilas University of Athens CASE OVERVIEW A 76-year-old male patient presented with progressive exertional dyspnoea refractory

More information

Cryptogenic Organizing Pneumonia: Serial High-Resolution CT Findings in 22 Patients

Cryptogenic Organizing Pneumonia: Serial High-Resolution CT Findings in 22 Patients Cardiopulmonary Imaging Original Research Lee et al. High-Resolution CT of Cryptogenic Organizing Pneumonia Cardiopulmonary Imaging Original Research Ju Won Lee 1 Kyung Soo Lee 1 Ho Yun Lee 1 Man Pyo Chung

More information

Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis

Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis ORIGINAL ARTICLE CANCER AND IPF Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis Eisuke Kato 1, Noboru Takayanagi 1, Yotaro Takaku 1, Naho Kagiyama 1, Tetsu

More information

Disclosures. Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting. Relevant financial relationships: None. Off-label usage: None

Disclosures. Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting. Relevant financial relationships: None. Off-label usage: None Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting Brandon T. Larsen, MD, PhD Senior Associate Consultant Department of Laboratory Medicine and Pathology Mayo Clinic Arizona Arizona

More information

In medicine, the term overlap is very common, to the extent that there is even a

In medicine, the term overlap is very common, to the extent that there is even a Case Report Payam Mehrian (MD) 1 Ali Cheraghvandi (MD) 2 Atousa Droudnia (PhD) 3 Firouzeh Talischi (MD) 4 Saeid Fallah Tafti (MD) *5 Shahram Kahkouee (MD) 6 Hamidreza Jamaati (MD) 7 1. Pediatric Respiratory

More information

[ Original Research Diffuse Lung Disease ]

[ Original Research Diffuse Lung Disease ] [ Original Research Diffuse Lung Disease ] Predicting Mortality in Systemic Sclerosis-Associated Interstitial Lung Disease Using Risk Prediction Models Derived From Idiopathic Pulmonary Fibrosis Christopher

More information

Shigeki Chiba, 1 Hiromitsu Ohta, 1 Kyoko Abe, 1 Shu Hisata, 1 Shinya Ohkouchi, 1 Yasushi Hoshikawa, 2 Takashi Kondo, 2 and Masahito Ebina 1

Shigeki Chiba, 1 Hiromitsu Ohta, 1 Kyoko Abe, 1 Shu Hisata, 1 Shinya Ohkouchi, 1 Yasushi Hoshikawa, 2 Takashi Kondo, 2 and Masahito Ebina 1 Pulmonary Medicine Volume 2012, Article ID 492960, 6 pages doi:10.1155/2012/492960 Research Article The Diagnostic Value of the Interstitial Biomarkers KL-6 and SP-D for the Degree of Fibrosis in Combined

More information

Usual Interstitial Pneumonia and Non-Specific Interstitial Pneumonia: Serial Thin-Section CT Findings Correlated with Pulmonary Function

Usual Interstitial Pneumonia and Non-Specific Interstitial Pneumonia: Serial Thin-Section CT Findings Correlated with Pulmonary Function Usual Interstitial Pneumonia and Non-Specific Interstitial Pneumonia: Serial Thin-Section CT Findings Correlated with Pulmonary Function Yeon Joo Jeong, MD 1, 2 Kyung Soo Lee, MD 1 Nestor L. Muller, MD

More information

Difficulties Diagnosing Idiopathic Pulmonary Fibrosis

Difficulties Diagnosing Idiopathic Pulmonary Fibrosis 1. er Encuentro Entre Neumólogos y Radiólogos, Madrid, Spain, 2016, October 14th Difficulties Diagnosing Idiopathic Pulmonary Fibrosis Simon Walsh King s College Hospital Foundation Trust London, United

More information

Idiopathic Pulmonary Fibrosis: A Study of 46 Patients from Western India: Clinical Presentations and Survival

Idiopathic Pulmonary Fibrosis: A Study of 46 Patients from Western India: Clinical Presentations and Survival Turk Thorac J 205; 6:4-20 DOI: 0.552/ttd.205.4584 ORIGINAL INVESTIGATION Idiopathic Pulmonary Fibrosis: A Study of 46 Patients from Western India: Clinical Presentations and Survival Subramanian Natarajan,

More information

Pathologic Assessment of Interstitial Lung Disease

Pathologic Assessment of Interstitial Lung Disease Pathologic Assessment of Interstitial Lung Disease Dry and itchy? It could be eczema or fungal infection. We don t need to worry, the drugs aren t that dangerous. Kirk D. Jones, MD UCSF Dept. of Pathology

More information

Unpaid scientific collaborator & advisor with Veracyte, Inc.

Unpaid scientific collaborator & advisor with Veracyte, Inc. Diagnosis and Classification of Idiopathic Interstitial Pneumonias: Role of Histopathology in the Golden Age of Consensus Jeffrey L. Myers, M.D. A. James French Professor of Diagnostic Pathology Vice Chair

More information

ERS 2016 Congress Highlights Interstitial Lung Disease (ILD)

ERS 2016 Congress Highlights Interstitial Lung Disease (ILD) ERS 216 Congress Highlights Interstitial Lung Disease (ILD) London, UK September 3 rd 7 th 216 The 26 th European Respiratory Society International Congress, (ERS) the largest respiratory meeting in the

More information

H ypersensitivity pneumonitis (HP) comprises a group of

H ypersensitivity pneumonitis (HP) comprises a group of 665 INTERSTITIAL LUNG DISEASE Chronic bird fancier s lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias

More information

IPF - Inquadramento clinico

IPF - Inquadramento clinico IPF - Inquadramento clinico Sergio Harari Unità Operativa di Pneumologia UTIR Servizio di Fisiopat. Resp. e Emodinamica Polmonare Ospedale S. Giuseppe, Milano Clinical Classification Diffuse parenchimal

More information

Initial presentation of idiopathic pulmonary fibrosis as an acute exacerbation

Initial presentation of idiopathic pulmonary fibrosis as an acute exacerbation Respiratory Medicine CME (2008) 1, 43 47 respiratory MEDICINE CME CASE REPORT Initial presentation of idiopathic pulmonary fibrosis as an acute exacerbation Krishna M. Sundar a,b,, Dixie L. Harris a a

More information

Subpleural Honeycombing on High Resolution Computed Tomography is Risk Factor for Fatal Pneumonitis

Subpleural Honeycombing on High Resolution Computed Tomography is Risk Factor for Fatal Pneumonitis Subpleural Honeycombing on High Resolution Computed Tomography is Risk Factor for Fatal Pneumonitis Hiroyuki Ito, MD, Haruhiko Nakayama, MD, Masahiro Tsuboi, MD, MD, Yoichi Kameda, MD, Tomoyuki Yokose,

More information

Relationship between fibroblastic foci profusion and high resolution CT morphology in fibrotic lung disease

Relationship between fibroblastic foci profusion and high resolution CT morphology in fibrotic lung disease Walsh et al. BMC Medicine (2015) 13:241 DOI 10.1186/s12916-015-0479-0 RESEARCH ARTICLE Relationship between fibroblastic foci profusion and high resolution CT morphology in fibrotic lung disease Open Access

More information

Idiopathic Pulmonary Fibrosis: The Importance of Qualitative and Quantitative Phenotyping

Idiopathic Pulmonary Fibrosis: The Importance of Qualitative and Quantitative Phenotyping Idiopathic Pulmonary Fibrosis: The Importance of Qualitative and Quantitative Phenotyping K. R. Flaherty Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor,

More information

Acute and Chronic Lung Disease

Acute and Chronic Lung Disease KATHOLIEKE UNIVERSITEIT LEUVEN Faculty of Medicine Acute and Chronic Lung Disease W De Wever, JA Verschakelen Department of Radiology, University Hospitals Leuven, Belgium Clinical utility of HRCT To detect

More information

Summary: Key Learning Points, Clinical Strategies, and Future Directions

Summary: Key Learning Points, Clinical Strategies, and Future Directions Summary: Key Learning Points, Clinical Strategies, and Future Directions Introduction Idiopathic pulmonary fibrosis (IPF), a peripheral lobular fibrosis of unknown cause, is a chronic, progressive lung

More information

Systemic lupus erythematosus (SLE): Pleuropulmonary Manifestations

Systemic lupus erythematosus (SLE): Pleuropulmonary Manifestations 08/30/10 09/26/10 Systemic lupus erythematosus (SLE): Pleuropulmonary Manifestations Camila Downey S. Universidad de Chile, School of Medicine, Year VII Harvard University, School of Medicine Sept 17,

More information

T he diagnostic evaluation of a patient with

T he diagnostic evaluation of a patient with 546 REVIEW SERIES Challenges in pulmonary fibrosis? 1: Use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias Michael B Gotway, Michelle M

More information

I n 2002 the American Thoracic Society (ATS) and

I n 2002 the American Thoracic Society (ATS) and 1008 REVIEW SERIES Challenges in pulmonary fibrosis? 5: The NSIP/UIP debate Roland du Bois, Talmadge E King Jr... Among the idiopathic interstitial s, the two entities idiopathic pulmonary fibrosis (IPF)

More information

Pulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment

Pulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment Prague, June 2014 Pulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment Katerina M. Antoniou, MD, PhD As. Professor in Thoracic Medicine ERS ILD Group Secretary Medical School,

More information

UIP OR NOT UIP PATTERN: THAT IS NOT THE ONLY QUESTION!

UIP OR NOT UIP PATTERN: THAT IS NOT THE ONLY QUESTION! UIP OR NOT UIP PATTERN: THAT IS NOT THE ONLY QUESTION! STÉPHANE JOUNEAU 11 JULY 2014 Respiratory Medicine Department, Pontchaillou Hospital, Rennes, France CASE OVERVIEW This case highlights how a usual

More information

HYPERSENSITIVITY PNEUMONITIS

HYPERSENSITIVITY PNEUMONITIS HYPERSENSITIVITY PNEUMONITIS A preventable fibrosis MOSAVIR ANSARIE MB., FCCP INTERSTITIAL LUNG DISEASES A heterogeneous group of non infectious, non malignant diffuse parenchymal disorders of the lower

More information

Manish Powari Regional Training Day 10/12/2014

Manish Powari Regional Training Day 10/12/2014 Manish Powari Regional Training Day 10/12/2014 Large number of different types of Interstitial Lung Disease (ILD). Most are very rare Most patients present with one of a smaller number of commoner diseases

More information

The pulmonary apical cap (PAC) has been recognized for

The pulmonary apical cap (PAC) has been recognized for Pulmonary Apical Cap What s Old Is New Again The pulmonary apical cap (PAC) is a morphologically distinct type of unilateral or bilateral fibroelastotic scar involving the lung apices. Despite being relatively

More information

Clinical course and outcome of rheumatoid arthritis-related usual interstitial pneumonia

Clinical course and outcome of rheumatoid arthritis-related usual interstitial pneumonia Original article: Clinical research SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES 2013; 30; 103-112 Mattioli 1885 Clinical course and outcome of rheumatoid arthritis-related usual interstitial pneumonia

More information

CT Scan Findings of Probable Usual Interstitial Pneumonitis Have a High Predictive Value for Histologic Usual Interstitial Pneumonitis

CT Scan Findings of Probable Usual Interstitial Pneumonitis Have a High Predictive Value for Histologic Usual Interstitial Pneumonitis [ Original Research Diffuse Lung Disease ] CT Scan Findings of Probable Usual Interstitial Pneumonitis Have a High Predictive Value for Histologic Usual Interstitial Pneumonitis Jonathan H. Chung, MD ;

More information

CT in Idiopathic Pulmonary Fibrosis: Diagnosis and Beyond

CT in Idiopathic Pulmonary Fibrosis: Diagnosis and Beyond Cardiopulmonary Imaging Review Gruden CT of Idiopathic Pulmonary Fibrosis Cardiopulmonary Imaging Review James F. Gruden 1 Gruden JF FOCUS ON: Keywords: CT, diagnosis, high-resolution CT, idiopathic pulmonary

More information